<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03696836</url>
  </required_header>
  <id_info>
    <org_study_id>AM-001</org_study_id>
    <nct_id>NCT03696836</nct_id>
  </id_info>
  <brief_title>AIR (Artificial Implant for Medial Meniscus Replacement) Study</brief_title>
  <acronym>AIR</acronym>
  <official_title>Treatment of Medial Knee Joint Pain With the Trammpolin® Meniscus Prosthesis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>ATRO Medical B.V.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>ATRO Medical B.V.</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The AIR Study is a multi-center, prospective, interventional clinical trial with the&#xD;
      objective to evaluate the safety and performance of the Trammpolin® meniscus prosthesis&#xD;
      system.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The Trammpolin® meniscus prosthesis is intended to replace the native medial meniscus to&#xD;
      provide pain relief in the medial compartment of the knee joint, when this is caused by&#xD;
      medial partial meniscectomy.&#xD;
&#xD;
      Patients who meet the inclusion/exclusion criteria and who are implanted with the Trammpolin®&#xD;
      meniscus prosthesis will be followed for 2 years. The patient reported outcome measures for&#xD;
      knee pain and function, and knee clinical condition by MRI and X-ray is assessed&#xD;
      post-operative compared to pre-operative.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Halted prematurely&#xD;
  </why_stopped>
  <start_date type="Actual">October 11, 2018</start_date>
  <completion_date type="Actual">July 1, 2021</completion_date>
  <primary_completion_date type="Actual">January 7, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Knee injury and Osteoarthritis Outcome Score (KOOS) Pain sub-scale</measure>
    <time_frame>24 Months</time_frame>
    <description>Performance of the Trammpolin® meniscus prosthesis in improving pain</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Trammpolin® meniscus prosthesis device related complications</measure>
    <time_frame>24 Months</time_frame>
    <description>The nature and frequency of all adverse events observed during the study</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>KOOS Pain sub-scale</measure>
    <time_frame>6 Weeks; 3, 6 and 12 Months</time_frame>
    <description>KOOS Pain sub-scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall KOOS scale</measure>
    <time_frame>6 Weeks; 3, 6, 12 and 24 Months</time_frame>
    <description>Overall KOOS scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lysholm scale</measure>
    <time_frame>6 Weeks; 3, 6, 12 and 24 Months</time_frame>
    <description>Lysholm scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC objective scale</measure>
    <time_frame>6 Weeks; 3, 6, 12 and 24 Months</time_frame>
    <description>IKDC objective scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee X-ray</measure>
    <time_frame>6 Weeks; 12 and 24 Months</time_frame>
    <description>Joint space measurement</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Knee MRI</measure>
    <time_frame>12 and 24 Months</time_frame>
    <description>Cartilage damage and extrusion</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">5</enrollment>
  <condition>Meniscectomy</condition>
  <condition>Osteo Arthritis Knee</condition>
  <arm_group>
    <arm_group_label>Trammpolin® meniscus prosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The patients will be implanted with the Trammpolin® meniscus prosthesis</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Trammpolin® meniscus prosthesis</intervention_name>
    <description>Trammpolin® meniscus prosthesis is an anatomically shaped, synthetic medial meniscus replacement</description>
    <arm_group_label>Trammpolin® meniscus prosthesis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Has medial compartment joint pain with &gt; 6 months ago a medial partial meniscectomy as&#xD;
             confirmed by patient history and MRI&#xD;
&#xD;
          2. Has a KOOS Pain of ≤ 75 (100 being no pain and the highest attainable score)&#xD;
&#xD;
          3. Is between age 30 and 65 years (inclusive) at the time of screening&#xD;
&#xD;
          4. Has neutral alignment ± 5° of the mechanical axis, i.e., the angle formed by a line&#xD;
             drawn from the center of the femoral head to the medial tibial spine and a line drawn&#xD;
             from the medial tibial spine to the center of the ankle joint, as confirmed by X-ray&#xD;
&#xD;
          5. Is willing to be implanted with the Trammpolin® meniscus prosthesis.&#xD;
&#xD;
          6. Is able to do the study required follow up visits, questionnaires, X-rays, CT-scans,&#xD;
             and MRI's&#xD;
&#xD;
          7. Is able and willing to understand and sign the study Informed Consent Form&#xD;
&#xD;
          8. Is able to read and understand the national language of the country in which the&#xD;
             relevant clinical site is located&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Has a symptomatic knee because of a tear that could be addressed by a repeat partial&#xD;
             meniscectomy&#xD;
&#xD;
          2. Has evidence of a modified Outerbridge Grade IV cartilage loss on the medial tibial&#xD;
             plateau or femoral condyle that potentially could contact a Trammpolin® meniscus&#xD;
             prosthesis (e.g., a focal lesion &gt; 0.5 cm2 correlating to a circular defect of &gt; 8 mm&#xD;
             in diameter)&#xD;
&#xD;
          3. Has lateral compartment pain and Grade III or Grade IV modified Outerbridge cartilage&#xD;
             score in the lateral compartment&#xD;
&#xD;
          4. Has a varus or valgus knee deformity of &gt; 5° requiring a tibial or femoral osteotomy&#xD;
&#xD;
          5. Has a varus alignment that is not passively correctable&#xD;
&#xD;
          6. Has a laxity level of more than Grade II (IKDC), primary or secondary to an injury of&#xD;
             the anterior cruciate ligament (ACL) and/or posterior cruciate ligament (PCL) and/or&#xD;
             lateral collateral ligament (LCL) and/or medial collateral ligament (MCL)&#xD;
&#xD;
          7. Has significant trochlear dysplasia, patellar instability or symptomatic patellar&#xD;
             misalignment&#xD;
&#xD;
          8. Has patellar compartment pain and Grade III or Grade IV modified Outerbridge cartilage&#xD;
             score in the patellar compartment.&#xD;
&#xD;
          9. Compared to a normal knee, has obvious radiological evidence of medial femoral&#xD;
             squaring, anatomical variance in the medial tibial plateau, or irregularly shaped&#xD;
             cartilage surface&#xD;
&#xD;
         10. Had an ACL reconstruction performed &lt; 9 months prior to surgery&#xD;
&#xD;
         11. Has a BMI &gt; 32.5 at the time of screening&#xD;
&#xD;
         12. Received any type of prosthetic knee implant made of artificial non-resorbable&#xD;
             plastic, metal or ceramic, not including the Trammpolin® meniscus prosthesis&#xD;
&#xD;
         13. Has a knee flexion contracture &gt; 10°&#xD;
&#xD;
         14. Has flexion &lt; 90°&#xD;
&#xD;
         15. Had a previous medial femoral condyle surgery (not including microfracture) or High&#xD;
             Tibial Osteotomy (HTO)&#xD;
&#xD;
         16. Has insufficiency fractures or avascular necrosis of the medial compartment&#xD;
&#xD;
         17. Has an active infection or tumor (local or systemic)&#xD;
&#xD;
         18. Has any type of knee joint inflammatory disease including Sjogren's syndrome&#xD;
&#xD;
         19. Has neuropathic knee osteoarthropathy, also known as Charcot joint&#xD;
&#xD;
         20. Has any medical condition that does not allow possible arthroscopy of the knee&#xD;
&#xD;
         21. Has neurological deficit (sensory, motor, or reflex)&#xD;
&#xD;
         22. Is currently involved in another investigation of the lower extremity&#xD;
&#xD;
         23. Anticipates having another lower extremity surgery during the study period&#xD;
&#xD;
         24. Is contraindicated for corticosteroid injections (i.e., patients with allergy to any&#xD;
             of the components or with idiopathic thrombocytopenic purpura)&#xD;
&#xD;
         25. Has received any corticosteroid knee injections ≤ 3 months prior to surgery&#xD;
&#xD;
         26. Has chondrocalcinosis&#xD;
&#xD;
         27. Has proven osteoporosis&#xD;
&#xD;
         28. Is on immunostimulating or immunosuppressing agents&#xD;
&#xD;
         29. Has ipsilateral or contralateral lower limb joint conditions that may affect&#xD;
             ambulation or KOOS (e.g. have a leg length discrepancy &gt; 2.5 cm [1 inch], causing a&#xD;
             noticeable limp)&#xD;
&#xD;
         30. Is a female who is lactating, expecting, or is intending to become pregnant during the&#xD;
             study period&#xD;
&#xD;
         31. Is an active smoker&#xD;
&#xD;
         32. Is mentally incapacitated (incapable of appraising or controlling conduct) or have&#xD;
             mental disability (e.g., dementia or Alzheimer's)&#xD;
&#xD;
         33. Is a prisoner&#xD;
&#xD;
         34. Has a condition or be in a situation that, in the Investigator's opinion, may confound&#xD;
             the study results, or may interfere significantly with the subject's participation in&#xD;
             the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht UMC+</name>
      <address>
        <city>Maastricht</city>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Radboud UMC</name>
      <address>
        <city>Nijmegen</city>
        <zip>6525 GA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Sint Maartenskliniek</name>
      <address>
        <city>Ubbergen</city>
        <zip>6574 NA</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>October 3, 2018</study_first_submitted>
  <study_first_submitted_qc>October 3, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 5, 2018</study_first_posted>
  <last_update_submitted>August 24, 2021</last_update_submitted>
  <last_update_submitted_qc>August 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

